[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10455-10456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03559]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Proposed Collection; 
Comment Request

    In compliance with Section 3506(c)(2)(A) of the Paperwork Reduction 
Act of 1995 concerning opportunity for public comment on proposed 
collections of information, the Substance Abuse and Mental Health 
Services Administration (SAMHSA) will publish periodic summaries of 
proposed projects. To request more information on the proposed projects 
or to obtain a copy of the information collection plans, call the 
SAMHSA Reports Clearance Officer on (240) 276-1243.
    Comments are invited on: (a) Whether the proposed collections of 
information are necessary for the proper performance of the functions 
of the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology.

Proposed Project: Program Evaluation for Prevention Contract (PEPC)--
Strategic Prevention Framework for Prescription Drugs (SPF-Rx) 
Evaluation (OMB No. 0930-0377)--Revision

    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ) 
aims to complete a cross-site evaluation of SAMHSA's Strategic 
Prevention Framework for Prescription Drugs (SPF-Rx). SPF-Rx is 
designed to address nonmedical use of prescription drugs as well as 
opioid overdoses by raising awareness about the dangers of sharing 
medications and by working with pharmaceutical and medical communities 
on the risks of overprescribing. The SPF-Rx program aims to promote 
collaboration between states/tribes and pharmaceutical and medical 
communities to understand the risks of overprescribing to youth ages 
12-17 and adults 18 years of age and older. The program also aims to 
enhance capacity for, and access to, Prescription Drug Monitoring 
Program (PDMP) data for prevention purposes. This request for data 
collection includes a revision from previously approved OMB 
instruments.
    The SPF-Rx program's indicators of success are reductions in opioid 
overdoses, reduction in prescription drug misuse and improved use of 
PDMP data. Data collected through the tools described in this statement 
will be used for the national cross-site evaluation of SAMHSA's SPF-Rx 
program. This package covers continued data collection through 2023. 
The PEPC team will systematically collect and maintain an Annual 
Implementation Instrument (AII) and Grantee and Community Level 
Outcomes data modules submitted by SPF-Rx grantees through the online 
Data Management System (DMS).
    SAMHSA is requesting approval for data collection for the SPF-Rx 
cross-site evaluation with the following instruments:
    Annual Implementation Instrument (AII)--The AII is a survey 
instrument collected yearly to monitor state, tribal entity, and 
community-level performance, and to evaluate the effectiveness of the 
SPF-Rx program. This tool is completed by grantees and sub-recipient 
community project directors, and provides process data related to 
funding use and effectiveness, organizational capacity, collaboration 
with community partners, data infrastructure, planned intervention 
targets, intervention implementation, evaluation, contextual factors, 
training and technical assistance (T/TA) needs, and sustainability.
    Grantee- and Community-Level Outcomes Modules--These modules 
collect data on key SPF-Rx program outcomes, including opioid 
prescribing patterns and provider use of PDMP. Grantees will provide 
outcomes data at the grantee level for their state, tribal area, or 
jurisdiction, as well as at the community level for each of their sub-
recipient communities.
    Grantee-Level Interview--This qualitative interview will be 
administered at the end of the evaluation to obtain information from 
the grantee project directors on their programs, staffing, populations 
of focus, infrastructure, capacity, lessons learned, and collaboration.

[[Page 10456]]



                                    Annualized Data Collection Burden by Year
----------------------------------------------------------------------------------------------------------------
                                    Number of     Responses per    Total number      Hours per     Total burden
           Instrument              respondents      respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Annual Implementation                       148                1             148               4             592
 Instrument....................
Grantee-Level Outcomes Module..              25                1              25             2.5            62.5
Community-Level Outcomes Module              25             4.92             123            1.25          153.75
Grantee-Level Interview........              25                1              25             1.5            37.5
                                --------------------------------------------------------------------------------
    FY2021.....................             223  ...............             321  ..............          845.75
----------------------------------------------------------------------------------------------------------------
Annual Implementation                       148                1             148               4             592
 Instrument....................
Grantee-Level Outcomes Module..              25                1              25             2.5            62.5
Community-Level Outcomes Module              25             4.92             123            1.25          154.75
                                --------------------------------------------------------------------------------
    FY2022.....................             198  ...............             296  ..............          808.25
----------------------------------------------------------------------------------------------------------------
Annual Implementation                        39                1              39               4             156
 Instrument....................
Grantee-Level Outcomes Module..               7                1               7             2.5            17.5
Community-Level Outcomes Module               7             4.57              32            1.25              40
                                --------------------------------------------------------------------------------
    FY2023.....................              53  ...............              78  ..............           213.5
----------------------------------------------------------------------------------------------------------------

    Send comments to Carlos Graham, SAMHSA Reports Clearance Officer, 
5600 Fishers Lane, Room 15E57-A, Rockville, Maryland 20857, OR email a 
copy to [email protected]. Written comments should be 
received by April 24, 2020.

Carlos Graham,
Social Science Analyst.
[FR Doc. 2020-03559 Filed 2-21-20; 8:45 am]
BILLING CODE 4162-20-P